Electrostatic influence on the kinetics of ligand binding to acetylcholinesterase. Distinctions between active center ligands and fasciculin.
To explore the role that surface and active center charges play in electrostatic attraction of ligands to the active center gorge of acetylcholinesterase (AChE), and the influence of charge on the reactive orientation of the ligand, we have studied the kinetics of association of cationic and neutral ligands with the active center and peripheral site of AChE. Electrostatic influences were reduced by sequential mutations of six surface anionic residues outside of the active center gorge (Glu-84, Glu-91, Asp-280, Asp-283, Glu-292, and Asp-372) and three residues within the active center gorge (Asp-74 at the rim and Glu-202 and Glu-450 at the base). The peripheral site ligand, fasciculin 2 (FAS2), a peptide of 6.5 kDa with a net charge of +4, shows a marked enhancement of rate of association with reduction in ionic strength, and this ionic strength dependence can be markedly reduced by progressive neutralization of surface and active center gorge anionic residues. By contrast, neutralization of surface residues only has a modest influence on the rate of cationic m-trimethylammoniotrifluoroacetophenone (TFK+) association with the active serine, whereas neutralization of residues in the active center gorge has a marked influence on the rate but with little change in the ionic strength dependence. Brownian dynamics calculations for approach of a small cationic ligand to the entrance of the gorge show the influence of individual charges to be in quantitative accord with that found for the surface residues. Anionic residues in the gorge may help to orient the ligand for reaction or to trap the ligand. Bound FAS2 on AChE not only reduces the rate of TFK+ reaction with the active center but inverts the ionic strength dependence for the cationic TFK+ association with AChE. Hence it appears that TFK+ must traverse an electrostatic barrier at the gorge entry imparted by the bound FAS2 with its net charge of +4.
Radić
Z
Z
Department of Pharmacology and of, University of California San Diego, La Jolla, California 92093-0636, USA.
Kirchhoff
P D
PD
Quinn
D M
DM
McCammon
J A
JA
Taylor
P
P
D000098:Acetophenones / Q000378:metabolism; D000110:Acetylcholinesterase / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D000122:Acetylthiocholine / Q000378:metabolism; D000818:Animals; D001665:Binding Sites; D002412:Cations / Q000378:metabolism; D002800:Cholinesterase Inhibitors / Q000378:metabolism; D004546:Elapid Venoms / Q000378:metabolism; D007700:Kinetics; D008024:Ligands; D051379:Mice; D008958:Models, Molecular; D016297:Mutagenesis, Site-Directed; D009596:Nitrophenols / Q000378:metabolism; D009994:Osmolar Concentration; D011487:Protein Conformation; D055672:Static Electricity; D013816:Thermodynamics
D000098:Acetophenones; D002412:Cations; D002800:Cholinesterase Inhibitors; D004546:Elapid Venoms; D008024:Ligands; D009596:Nitrophenols; D000122:Acetylthiocholine; C008642:4-nitrophenyl acetate; C044937:fasciculin; D000110:Acetylcholinesterase